MedPath

SALZMANN PRODUCTS A-8 APSORA

SALZMANN PRODUCTS A-8 APSORA

Discontinued
DIN Number

00696404

Drug Class

Human

Market Date

Dec 31, 1986

Company
HC

biocentre

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00696404
AIG Number0618316001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (6)

CALCIUM SULFATEActive
Strength: 6 X / X
Monograph: CALCIUM SULFATE
POTASSIUM SULFATEActive
Strength: 6 X / X
Monograph: POTASSIUM SULFATE
SILICON DIOXIDEActive
Strength: 30 X / X
Monograph: SILICON DIOXIDE
SODIUM PHOSPHATE DIBASICActive
Strength: 6 X / X
Monograph: SODIUM PHOSPHATE DIBASIC
SULFURActive
Strength: 6 X / X
Monograph: SULFUR
SULFUR IODIDEActive
Strength: 60 X / X
Monograph: SULFUR IODIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.